Literature DB >> 2050176

Interaction of metoprolol with lorazepam and bromazepam.

A K Scott1, G A Cameron, G M Hawksworth.   

Abstract

The interaction between metoprolol and bromazepam and lorazepam was studied in 12 healthy male volunteers aged 21-37 years. Metoprolol had no significant effect on the pharmacokinetics of bromazepam or lorazepam. However, bromazepam AUC was 35% higher in the presence of metoprolol. Bromazepam enhanced the effect of metoprolol on systolic blood pressure but not on diastolic blood pressure or pulse rate. Lorazepam had no effect on either blood pressure or pulse. Metoprolol did not enhance the effect of bromazepam on the psychomotor tests used in this study. Metoprolol caused a small increase in critical flicker fusion threshold with lorazepam but had no effect on the other tests. Lorazepam (2 mg) was more potent than bromazepam (6 mg) in the doses used in this study. The interaction of metoprolol with bromazepam and lorazepam is unlikely to be of clinical significance. No change in dose is necessary when using these drugs together.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050176     DOI: 10.1007/bf00265852

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

2.  Effect of beta-blockers on psychomotor performance in normal volunteers.

Authors:  T A Betts; R Knight; A Crowe; A Blake; P Harvey; D Mortiboy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Propranolol interactions with diazepam, lorazepam, and alprazolam.

Authors:  H R Ochs; D J Greenblatt; B Verburg-Ochs
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

4.  Diazepam/beta-adrenoceptor antagonist interactions.

Authors:  G Hawksworth; T Betts; A Crowe; R Knight; I Nyemitei-Addo; K Parry; J C Petrie; A Raffle; A Parsons
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

5.  Oxazepam pharmacokinetics in thyroid disease.

Authors:  A K Scott; A S Khir; P D Bewsher; G M Hawksworth
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

6.  Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol.

Authors:  H R Ochs; D J Greenblatt; H Friedman; E S Burstein; A Locniskar; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1987-05       Impact factor: 6.875

7.  Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with phenobarbitone.

Authors:  A K Scott; A S Khir; W H Steele; G M Hawksworth; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

8.  The effect of propranolol on paracetamol metabolism in man.

Authors:  O Z Baraka; C A Truman; J M Ford; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

9.  Effects of microsomal enzyme induction on paracetamol metabolism in man.

Authors:  L F Prescott; J A Critchley; M Balali-Mood; B Pentland
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

10.  Cimetidine spares the glucuronidation of lorazepam and oxazepam.

Authors:  R V Patwardhan; G W Yarborough; P V Desmond; R F Johnson; S Schenker; K V Speeg
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

View more
  1 in total

Review 1.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.